Research reagents vs approved medicines: what the label means in the GCC

Two very different kinds of product carry the word “peptide” in the Gulf. One is the registered medicine: a peptide-based drug that a national authority has assessed for quality, safety and efficacy, and that a licensed pharmacy or clinician supplies under defined conditions. The other is the research reagent: a synthetic peptide sold for laboratory work and labelled “for research use only”, with no claim that it has been assessed for any use in people or animals.

The same name, or a similar one, can appear in both worlds. The two are not interchangeable, and this guide explains why the difference matters for anyone reading a supplier listing in the GCC.

What registration means

A registered medicine has passed through a national approval process. In the GCC that means, for example, the Emirates Drug Establishment in the UAE, the Saudi Food and Drug Authority, or the relevant ministry departments in Kuwait, Qatar, Bahrain and Oman. Registration covers the specific product: its manufacturer, formulation, strength, labelling and conditions of supply. It is not a property of the molecule alone.

Two practical consequences follow:

• A medicine registered in one country is not automatically registered in its neighbours. Each GCC authority keeps its own register, and the country hubs on this site link to the official directories where they exist.
• A molecule appearing in a research catalogue tells you nothing about whether any product containing it is registered anywhere.

What “research use only” means

“Research use only” (RUO) is a supplier’s statement about intended use. Regulators have discussed the label for decades. The US FDA’s guidance on in-vitro diagnostic products labelled “for research use only”, for example, is concerned with products being marketed under that label for uses they were never assessed for. Applied to peptides, the label means the seller makes no representation that the material is suitable for anything except laboratory work.

Most suppliers in our directory use some form of this wording. Typical phrasing on GCC storefronts includes “in vitro laboratory research only” and “not for human or animal consumption”. Those sentences are consistent with the label. Product pages that discuss benefits in people, or provide calculators and protocols framed around personal use, are not.

Quality systems are different too

A registered medicine is made under good manufacturing practice (GMP) and released against a specification the regulator has accepted. A research reagent is usually documented by a certificate of analysis (COA), which describes one tested sample from one batch. It can be a useful document, and in our directory two suppliers publish a browsable library of batch certificates, but it is not a GMP release. Our guide How to read a certificate of analysis sets out what a COA can and cannot tell you.

The World Health Organization’s work on substandard and falsified medical products shows why documentation matters even within the regulated system. Outside it, the burden of checking falls entirely on the buyer.

Legality is a separate question again

Whether a research peptide can lawfully be bought, held or imported in a given GCC country is not answered by either label. It depends on that country’s rules, on who is importing (an individual, a company or a licensed laboratory), and sometimes on the format. The supplier policies we captured all place customs duties and import requirements on the recipient, and several say parcels held or seized by customs are not refunded.

That is why this atlas never says a product is “legal in the GCC”. Each country hub has a regulations page that names the relevant authorities, links their official sites and lists the questions worth asking them.

How to read a listing with this in mind

1. Look for the research-use statement and check that the rest of the page is consistent with it.
2. Do not treat a research listing as a cheaper version of a medicine. They are different products, made and documented under different systems.
3. Read the certificate for the batch you would receive, and verify it with the laboratory where possible.
4. Check your country’s rules before ordering, not after a parcel is held.